Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Henry Schein, Inc.
Henry Schein, Inc. News
Henry Schein, Inc. Quantitative Score
About Henry Schein, Inc.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Henry Schein, Inc. Earnings & Revenue
Henry Schein, Inc. Financials
Table Compare
Compare HSIC metrics with: | |||
|---|---|---|---|
Earnings & Growth | HSIC | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | HSIC | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | HSIC | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | HSIC | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Henry Schein, Inc. Income
Henry Schein, Inc. Balance Sheet
Henry Schein, Inc. Cash Flow
Henry Schein, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Buy |
| Return on Assets | Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Henry Schein, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Henry Schein, Inc. Executives
| Name | Role |
|---|---|
| Mr. Stanley M. Bergman | Executive Chairman & Chief Executive Officer |
| Mr. James P. Breslawski | President |
| Mr. Mark E. Mlotek | Executive Vice President, Chief Strategic Officer & Executive Director |
| Mr. Michael Saul Ettinger | Executive Vice President & Chief Operating Officer |
| Mr. Ronald N. South | Senior Vice President & Chief Financial Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Stanley M. Bergman | Executive Chairman & Chief Executive Officer | Male | 1950 | 2.61M |
| Mr. James P. Breslawski | President | Male | 1954 | 1.44M |
| Mr. Mark E. Mlotek | Executive Vice President, Chief Strategic Officer & Executive Director | Male | 1956 | 1.35M |
| Mr. Michael Saul Ettinger | Executive Vice President & Chief Operating Officer | Male | 1961 | 1.18M |
| Mr. Ronald N. South | Senior Vice President & Chief Financial Officer | Male | 1962 | 1M |
Henry Schein, Inc. Insider Trades
| Date | 6 Sep |
| Name | McGlynn Lorelei |
| Role | SVP, Chief Human Res. Officer |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 21035 |
| Date | 14 Aug |
| Name | MLOTEK MARK E |
| Role | EVP, Chief Strategic Officer |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 3000 |
| Date | 12 Aug |
| Name | BERGMAN STANLEY M |
| Role | Chairman, CEO |
| Transaction | Disposed |
| Type | G-Gift |
| Shares | 1560 |
| Date | 9 Aug |
| Name | Ettinger Michael S |
| Role | EVP & Chief Operating Officer |
| Transaction | Disposed |
| Type | G-Gift |
| Shares | 145 |
| Date | 7 Jun |
| Name | Margulies Anne H. |
| Role | Director |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 714 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 6 Sep | McGlynn Lorelei | SVP, Chief Human Res. Officer | Disposed | S-Sale | 21035 |
| 14 Aug | MLOTEK MARK E | EVP, Chief Strategic Officer | Disposed | S-Sale | 3000 |
| 12 Aug | BERGMAN STANLEY M | Chairman, CEO | Disposed | G-Gift | 1560 |
| 9 Aug | Ettinger Michael S | EVP & Chief Operating Officer | Disposed | G-Gift | 145 |
| 7 Jun | Margulies Anne H. | Director | Disposed | F-InKind | 714 |